Inventor · disambiguated record
Gary Liversidge
Also filed as: LIVERSIDGE GARY · LIVERSIDGE GARY G
29 granted patents·84 pending applications·7,278 citations·filing 1991–2017
98Inventor score
Files withELAN PHARMA INT LTD58ELAN CORP PLC11ALKERMES PHARMA IRELAND LTD6LIVERSIDGE GARY6EASTMAN KODAK CO4
Top patents by PatentIndex Score
113 records- 0199US5145684ASurface modified drug nanoparticlesSTERLING DRUG INC·Filed 1991·Granted Sep 8, 1992·2.1k cites·20 claims
- 0298US5494683ASurface modified anticancer nanoparticlesEASTMAN KODAK CO·Filed 1994·Granted Feb 27, 1996·328 cites·4 claims
- 0398US5399363ASurface modified anticancer nanoparticlesEASTMAN KODAK CO·Filed 1992·Granted Mar 21, 1995·1k cites·17 claims
- 0498US5302401AMethod to reduce particle size growth during lyophilizationSTERLING WINTHROP INC·Filed 1992·Granted Apr 12, 1994·410 cites·4 claims
- 0597US6432381B2Methods for targeting drug delivery to the upper and/or lower gastrointestinal tractELAN PHARMA INT LTD·Filed 1997·Granted Aug 13, 2002·214 cites·27 claims
- 0697US6045829ANanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizersELAN PHARMA INT LTD·Filed 1997·Granted Apr 4, 2000·329 cites·22 claims
- 0797US5580579ASite-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymersNANO SYS LLC·Filed 1995·Granted Dec 3, 1996·357 cites·15 claims
- 0896US6221400B1Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitorsELAN PHARMA INT LTD·Filed 1999·Granted Apr 24, 2001·215 cites·13 claims
- 0996US5628981AFormulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agentsNANO SYS LLC·Filed 1994·Granted May 13, 1997·172 cites·10 claims
- 1096US5585108AFormulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable claysNANOSYSTEMS LLC·Filed 1994·Granted Dec 17, 1996·244 cites·4 claims
- 1196US5552160ASurface modified NSAID nanoparticlesNANOSYSTEMS LLC·Filed 1995·Granted Sep 3, 1996·478 cites·13 claims
- 1296US5318767AX-ray contrast compositions useful in medical imagingSTERLING WINTHROP INC·Filed 1992·Granted Jun 7, 1994·291 cites·28 claims
- 1395USRE41884EReduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactionsELAN PHARMA INT LTD·Filed 2008·Granted Oct 26, 2010·26 cites·35 claims
- 1495US5834025AReduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactionsNANOSYSTEMS LLC·Filed 1996·Granted Nov 10, 1998·173 cites·20 claims
- 1595US5451393AX-ray contrast compositions useful in medical imagingEASTMAN KODAK CO·Filed 1994·Granted Sep 19, 1995·171 cites·21 claims
- 1694US5466440AFormulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable claysEASTMAN KODAK CO·Filed 1994·Granted Nov 14, 1995·155 cites·8 claims
- 1793US7910577B2Injectable nanoparticulate olanzapine formulationsELAN PHARMA INT LTD·Filed 2005·Granted Mar 22, 2011·27 cites·17 claims
- 1893US6068858AMethods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizersELAN PHARMA INTERNATIONAL LIMI·Filed 1999·Granted May 30, 2000·232 cites·18 claims
- 1993US5593657ABarium salt formulations stabilized by non-ionic and anionic stabilizersNANOSYSTEMS LLC·Filed 1995·Granted Jan 14, 1997·161 cites·22 claims
- 2091US7763278B2Nanoparticulate polycosanol formulations and novel polycosanol combinationsELAN PHARMA INT LTD·Filed 2003·Granted Jul 27, 2010·42 cites·66 claims
- 2190US8158153B2Nanoparticulate bisphosphonate compositionsLIVERSIDGE GARY G·Filed 2006·Granted Apr 17, 2012·19 cites·12 claims
- 2289US7825087B2Nanoparticulate and controlled release compositions comprising cyclosporineELAN PHARMA INT LTD·Filed 2006·Granted Nov 2, 2010·5 cites·16 claims
- 2387US8119163B2Nanoparticulate and controlled release compositions comprising cefditorenDEVANE JOHN G·Filed 2007·Granted Feb 21, 2012·15 cites·22 claims
- 2487US8003127B2Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereofELAN PHARMA INT LTD·Filed 2006·Granted Aug 23, 2011·10 cites·24 claims
- 2585US8623412B2Abuse-resistant pharmaceutical compositionsVAGHEFI FARID·Filed 2003·Granted Jan 7, 2014·25 cites·7 claims
- 2684US8309133B2Nanoparticulate quinazoline derivative formulationsLIVERSIDGE GARY G·Filed 2006·Granted Nov 13, 2012·4 cites·19 claims
- 2779US8293277B2Controlled-release nanoparticulate compositionsSWANSON JON·Filed 1999·Granted Oct 23, 2012·45 cites·28 claims
- 2878US8367112B2Nanoparticulate carverdilol formulationsALKERMES PHARMA IRELAND LTD·Filed 2006·Granted Feb 5, 2013·3 cites·22 claims
- 2975US2009155331A1Injectable nanoparticulate olanzapine formulationsELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 3068US2013309310A1Injectable Nanoparticulate Olanzapine FormulationsALKERMES PHARMA IRELAND LTD·Filed 2013·Application pending·0 cites
- 3167US2014248341A1Alcohol resistant enteric pharmaceutical compositionsALKERMES PHARMA IRELAND LTD·Filed 2014·Application pending·0 cites
- 3266US2009297619A1Nanoparticulate anticonvulsant and immunosuppressive compositionsELAN PHARMA INT LTD·Filed 2009·Application pending·0 cites
- 3365US8236352B2Glipizide compositionsBOSCH H WILLIAM·Filed 2003·Granted Aug 7, 2012·1 cites·49 claims
- 3464US2007098805A1Methods of making and using novel griseofulvin compositionsELAN PHARMA INT LTD·Filed 2006·Application pending·0 cites
- 3564US2009291142A1Nanoparticulate bicalutamide formulationsELAN PHARMA INT LTD·Filed 2009·Application pending·0 cites
- 3664US2009252806A1Nanoparticulate tacrolimus formulationsELAN PHARMA INT LTD·Filed 2009·Application pending·0 cites
- 3764US2006159767A1Nanoparticulate bicalutamide formulationsELAN PHARMA INT LTD·Filed 2005·Application pending·0 cites
- 3862US2008248123A1Nanoparticulate anticonvulsant and immunosuppressive compositionsELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 3962US2018085315A1Alcohol resistant enteric pharmaceutical compositionsALKERMES PHARMA IRELAND LTD·Filed 2017·Application pending·0 cites
- 4062US2011008435A1Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic CompoundsELAN CORP PLC·Filed 2007·Application pending·0 cites
- 4161US2008152720A1Nanoparticulate tacrolimus formulationsELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 4261US2009304801A1Aerosol and injectable formulations of nanoparticulate benzodiazepineELAN PHARMA INT LTD·Filed 2009·Application pending·0 cites
- 4361US2015238505A1Injectable nanoparticulate olanzapine formulationsALKERMES PHARMA IRELAND LTD·Filed 2015·Application pending·0 cites
- 4461US2006240105A1Multiparticulate modified release compositionELAN CORP PLC·Filed 2006·Application pending·0 cites
- 4561US2009149479A1Dosing regimenELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 4660US2005004049A1Novel griseofulvin compositionsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 4760US2009227554A1Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimensELAN PHARM INC·Filed 2009·Application pending·0 cites
- 4859US2011159054A1Nanoparticulate bicalutamide formulationsELAN PHARMA INT LTD·Filed 2011·Application pending·0 cites
- 4959US2003054045A1Formulations for therapeutic agents absorbed through mucous membranesELAN PHARMA INT LTD·Filed 2002·Application pending·0 cites
- 5058US2009035366A1Nanoparticulate benzothiophene formulationsELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
Showing the top 50 of 113 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gary Liversidge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →